BIOREGENX, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bioregenx, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q4 2024.
  • Bioregenx, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$18.4M, a 7067% decline year-over-year.
  • Bioregenx, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$23.1M, a 540% decline year-over-year.
  • Bioregenx, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$23.1M, a 540% decline from 2023.
  • Bioregenx, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.6M, a 4497% decline from 2022.
  • Bioregenx, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$78.3K, a 19.2% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$23.1M -$18.4M -$18.1M -7067% Oct 1, 2024 Dec 31, 2024 10-K/A 2025-04-16
Q3 2024 -$4.91M -$395K +$2.12M +84.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$7.03M -$1.11M -$512K -86.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-09
Q1 2024 -$6.52M -$3.15M -$2.92M -1272% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-10-09
Q4 2023 -$3.6M -$257K -$251K -4539% Oct 1, 2023 Dec 31, 2023 10-K/A 2025-04-16
Q3 2023 -$3.35M -$2.52M -$2.52M -114872% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$832K -$594K -$561K -1687% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-09
Q1 2023 -$271K -$230K -$193K -516% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-10-09
Q4 2022 -$78.3K -$5.54K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 -$2.19K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$33.3K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$37.3K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.